TradeStation Group Announces New President
Mar 07, 2016 12:40 pm UTC| Business
PLANTATION, Fla., March 07, 2016 -- TradeStation Group, Inc., parent company of TradeStation Securities, the award-winning broker-dealer and futures commission merchant, today announced that Salomon Sredni will retire...
Mar 07, 2016 12:38 pm UTC| Business
RAMSEY, N.J., March 07, 2016 -- ADMA Biologics, Inc. (NASDAQ:ADMA), a late-stage biopharmaceutical company that develops, manufactures, and intends to commercialize specialty plasma-based biologics for the treatment and...
Mar 07, 2016 12:36 pm UTC| Business
Albany, NY , March 07, 2016 -- According to a new market report published by Transparency Market Research “Teleradiology Market - Western Europe Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023”,...
Strongbridge Biopharma plc Provides Update on Corporate Progress
Mar 07, 2016 12:30 pm UTC| Business
Strongbridge Prioritizes Rare Endocrine Disease Portfolio Focus on COR-003 and COR-005 Strongbridge Provides Update on Cash Position – Existing Cash Sufficient to Fund Planned Operations Beyond Receipt of Data From...
TG Therapeutics, Inc. to Present at Upcoming Investment Conferences
Mar 07, 2016 12:30 pm UTC| Business
NEW YORK, March 07, 2016 -- TG Therapeutics, Inc. (Nasdaq:TGTX) today announced its participation at two upcoming investment conferences. Michael S. Weiss, the Company’s Executive Chairman and Interim Chief Executive...
Alliqua BioMedical, Inc. Announces Expansion of Medicare Reimbursement Coverage for Biovance®
Mar 07, 2016 12:30 pm UTC| Business
YARDLEY, Pa., March 07, 2016 -- Alliqua BioMedical, Inc. (Nasdaq:ALQA) ("Alliqua" or "the Company"), a provider of advanced wound care products, today announced that Biovance® Human Amniotic Membrane Allograft is now...
Marinus Pharmaceuticals Provides Business Update and 2015 Financial Results
Mar 07, 2016 12:30 pm UTC| Business
RADNOR, Pa., March 07, 2016 -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS), a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today...